Boston Scientific Corporation
BSX
$101.49
$2.572.59%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 414.00M | 2.50B | 2.91B | 2.33B | 865.00M |
| Total Receivables | 2.56B | 2.50B | 2.40B | 2.30B | 2.23B |
| Inventory | 2.81B | 2.75B | 2.61B | 2.56B | 2.48B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.14B | 1.01B | 1.07B | 991.00M | 937.00M |
| Total Current Assets | 6.92B | 8.76B | 8.99B | 8.19B | 6.51B |
|
|
|||||
| Total Current Assets | 6.92B | 8.76B | 8.99B | 8.19B | 6.51B |
| Net Property, Plant & Equipment | 3.74B | 3.50B | 3.37B | 3.33B | 3.30B |
| Long-term Investments | 17.09B | 15.03B | 14.40B | 14.36B | 14.39B |
| Goodwill | 17.09B | 15.03B | 14.40B | 14.36B | 14.39B |
| Total Other Intangibles | 6.68B | 5.76B | 5.43B | 5.86B | 6.00B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.40B | 4.50B | 4.47B | 4.51B | 4.52B |
| Total Assets | 39.40B | 38.08B | 37.11B | 36.67B | 35.14B |
|
|
|||||
| Total Accounts Payable | 960.00M | 907.00M | 906.00M | 921.00M | 942.00M |
| Total Accrued Expenses | 2.53B | 2.27B | 2.03B | 1.77B | 2.14B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.86B | 1.65B | 1.58B | 1.09B | 607.00M |
| Total Finance Division Other Current Liabilities | 1.05B | 1.08B | 1.06B | 1.14B | 1.25B |
| Total Other Current Liabilities | 1.05B | 1.08B | 1.06B | 1.14B | 1.25B |
| Total Current Liabilities | 6.40B | 5.91B | 5.58B | 4.92B | 4.93B |
|
|
|||||
| Total Current Liabilities | 6.40B | 5.91B | 5.58B | 4.92B | 4.93B |
| Long-Term Debt | 8.84B | 9.23B | 8.99B | 9.53B | 8.57B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 527.00M | 377.00M | 369.00M | 386.00M | 395.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.62B | 1.61B | 1.57B | 1.67B | 1.71B |
| Total Liabilities | 17.39B | 17.12B | 16.50B | 16.50B | 15.61B |
|
|
|||||
| Common Stock & APIC | 21.07B | 20.98B | 20.82B | 20.73B | 20.66B |
| Retained Earnings | 2.67B | 2.11B | 1.64B | 1.31B | 819.00M |
| Treasury Stock & Other | -1.98B | -2.38B | -2.09B | -2.12B | -2.20B |
| Total Common Equity | 21.77B | 20.71B | 20.37B | 19.93B | 19.28B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.77B | 20.71B | 20.37B | 19.93B | 19.28B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 233.00M | 248.00M | 238.00M | 242.00M | 248.00M |
| Total Equity | 22.00B | 20.96B | 20.61B | 20.17B | 19.53B |
|
|
|||||